Reliance on hospital discharge diagnosis codes alone will likely underestimate the burden of respiratory viruses ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2017
• November 2017

Palivizumab appeared effective for reducing virologically confirmed respiratory syncytial virus in this high-risk cohort ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2019
• November 2019

Researchers at Telethon Kids Institute and UWA will use a $500,000 CUREator grant to progress the development of the first cancer immunotherapy in a tablet. ...

• 1. Telethon Kids Institute
• News & Events
• News & Events at Telethon Kids
• 2022
• August

Researchers using powerful microscopes have identified bacterial slime in the lungs of some children with persistent wet coughs. ...

• 1. Telethon Kids Institute
• News & Events
• News & Events at Telethon Kids
• 2022
• February

Professor Andrew Whitehouse awarded the most prestigious award in the country for young researchers – the 3M Eureka Prize for Emerging Leader in Science. ...

• 1. Telethon Kids Institute
• News & Events
• News & Events at Telethon Kids
• 2017
• August

Children with comorbidities are at greater risk of severe influenza outcomes compared with healthy children. In Australia, influenza vaccination was funded for those with comorbidities from 2010 and all children aged <5 years from 2018. Influenza vaccine coverage remains inadequate in children with and without comorbidities. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2022
• March 2022

The monoclonal antibody, palivizumab is licensed for use in high-risk infants to prevent severe illness caused by respiratory syncytial virus (RSV). The level of its use and compliance with current jurisdictional guidelines which were amended in 2010, is unknown. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2020
• October 2020

We outline the processes involved in conducting a Proof of Concept data linkage project including the implementation of national data integration principles ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2016
• January 2016

Respiratory syncytial virus (RSV) remains a leading cause of mortality and morbidity worldwide. RSV seasonality was disrupted by COVID-19-associated nonpharmaceutical interventions (NPIs). We review RSV seasonality, molecular epidemiology, clinical manifestations, and community awareness to inform future prevention strategies.  ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• December 2023

Asthma is among the commonest noncommunicable diseases of childhood and often occurs with other atopic comorbidities. A previous case-control study found evidence that compared to children who received acellular pertussis (aP) vaccines in early infancy, children who received one or more doses of whole-cell pertussis (wP) vaccine had lower risk of developing IgE-mediated food allergy. We hypothesized that wP vaccination in early infancy might protect against atopic asthma in childhood.  ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• October 2023